Stockreport

ReShape Lifesciences misses by $0.77, misses on revenue [Seeking Alpha]

ReShape Lifesciences, Inc.  (RSLS) 
US:NASDAQ Investor Relations: ir.enteromedics.com
PDF ReShape Lifesciences misses by $0.77, misses on revenueReShape Lifesciences (NASDAQ:RSLS): Q3 EPS of -$1.06misses by $0.77.Revenue of $0.11M (-63.3% Y/Y)misses by $0.2M. [Read more]